The Use of Galantamine HBr (Reminyl) in Electroconvulsive Therapy: Impact on Mood and Cognitive Functioning

Clinical trial NCT00566735 · COMPLETED

Trial details

NCT number: NCT00566735
Sponsor: Massachusetts General Hospital
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Major Depression Bipolar Depression Schizoaffective Disorder

Start date: 2004-07-01
Primary completion: 2008-01-01
Enrollment: 39

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.